Renaissance Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.76M | Buy |
18,349
+4,259
| +30% | +$1.34M | 0.22% | 112 |
|
2025
Q1 | $4.29M | Buy |
14,090
+2,567
| +22% | +$782K | 0.19% | 113 |
|
2024
Q4 | $3.83M | Buy |
11,523
+1,168
| +11% | +$388K | 0.16% | 115 |
|
2024
Q3 | $3.46M | Buy |
10,355
+56
| +0.5% | +$18.7K | 0.14% | 116 |
|
2024
Q2 | $4.24M | Sell |
10,299
-712
| -6% | -$293K | 0.17% | 110 |
|
2024
Q1 | $4.45M | Buy |
11,011
+2,025
| +23% | +$818K | 0.17% | 109 |
|
2023
Q4 | $2.76M | Sell |
8,986
-563
| -6% | -$173K | 0.11% | 128 |
|
2023
Q3 | $2.31M | Buy |
9,549
+113
| +1% | +$27.4K | 0.11% | 124 |
|
2023
Q2 | $2.27M | Buy |
9,436
+534
| +6% | +$128K | 0.1% | 127 |
|
2023
Q1 | $1.67M | Buy |
8,902
+574
| +7% | +$108K | 0.08% | 164 |
|
2022
Q4 | $1.77M | Buy |
8,328
+125
| +2% | +$26.6K | 0.09% | 119 |
|
2022
Q3 | $1.29M | Buy |
8,203
+266
| +3% | +$41.8K | 0.07% | 152 |
|
2022
Q2 | $1.19M | Buy |
7,937
+392
| +5% | +$58.7K | 0.06% | 161 |
|
2022
Q1 | $1.23M | Buy |
7,545
+388
| +5% | +$63.5K | 0.06% | 160 |
|
2021
Q4 | $1.56M | Buy |
7,157
+310
| +5% | +$67.5K | 0.06% | 129 |
|
2021
Q3 | $1.3M | Sell |
6,847
-96
| -1% | -$18.2K | 0.06% | 131 |
|
2021
Q2 | $1.23M | Sell |
6,943
-1,170
| -14% | -$207K | 0.05% | 141 |
|
2021
Q1 | $1.33M | Buy |
8,113
+262
| +3% | +$43K | 0.06% | 124 |
|
2020
Q4 | $1.09M | Buy |
7,851
+38
| +0.5% | +$5.29K | 0.05% | 135 |
|
2020
Q3 | $873K | Buy |
7,813
+38
| +0.5% | +$4.25K | 0.04% | 133 |
|
2020
Q2 | $723K | Sell |
7,775
-68
| -0.9% | -$6.32K | 0.03% | 159 |
|
2020
Q1 | $576K | Sell |
7,843
-1,343
| -15% | -$98.6K | 0.03% | 176 |
|
2019
Q4 | $772K | Buy |
9,186
+3,440
| +60% | +$289K | 0.03% | 171 |
|
2019
Q3 | $483K | Sell |
5,746
-3,113
| -35% | -$262K | 0.02% | 203 |
|
2019
Q2 | $580K | Buy |
+8,859
| New | +$580K | 0.02% | 182 |
|